World COPD Day: Lung Association Launches Campaign to Improve Care for 12.5 million Americans Living with COPD
16 Nov 2022
AHA
American Lung Association amps up education and awareness about chronic lung disease
CHICAGO, Nov. 16, 2022 /PRNewswire/ -- Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and death in the United States. More than 12.5 million people have been diagnosed with COPD, but millions more may have the disease without even knowing it. Today, on World COPD Day, the American Lung Association aims to increase awareness about COPD, including the critical need to improve screening, early diagnosis and the quality of life for people living with the disease.
COPD, which includes chronic bronchitis and emphysema, is a long-term lung disease that gets worse over time. With COPD, less air flows in and out of the lungs which makes it harder for a person to breathe. As the disease gets worse, increased shortness of breath makes it harder to remain active.
"Currently, there is no cure for COPD, but the good news is that it is preventable and treatable," said Harold Wimmer, National President and CEO for the American Lung Association. "Early detection is key to successfully treating COPD, however many people don't recognize the symptoms until later stages of the disease. This is why nationwide awareness is needed to educate public health and healthcare professionals about the disease, including prevention, screening and guidelines for treatment and management of COPD."
The American Lung Association's "Addressing COPD" project, funded with support by the Centers for Disease Control and Prevention (CDC), will utilize a coordinated, comprehensive public health approach to improve prevention, early diagnosis, treatment and management of COPD. To do this, the Lung Association will engage a network of strategic community partners to increase knowledge and adoption of evidence-based strategies that improve COPD morbidity and mortality across the United States.
As a part of this project, the American Lung Association's COPD Trends Brief was updated with the latest CDC data. The COPD Trends Brief will inform healthcare systems, policy makers, community leaders and the public about who is most affected by COPD and how widespread the impact of COPD is on Americans.
More About COPD
COPD is caused by long-term exposure to irritants that damage the airways in your lungs like cigarette smoking; breathing secondhand smoke; exposure to air pollution; working with chemicals, dust and fumes; or sometimes a genetic condition called Alpha-1 deficiencyAlpha-1 deficiency or a history of childhood respiratory infection. About 75% of all COPD cases are caused by cigarette smoking. Symptoms of COPD include chronic cough, shortness of breath while doing everyday activities, trouble taking a deep breath, producing a lot of mucus (sputum or phlegm) and wheezing.
Women are often misdiagnosed because COPD is sometimes thought of as a "man's disease" or an "old person's disease." However, more women are diagnosed with and die from COPD. In addition, women tend to develop the disease between ages of 45 to 64 which is younger than when men are typically diagnosed.
There are several treatment options for COPD. Treatments may include medication, lifestyle changes like quitting smoking, pulmonary rehabilitation, supplemental oxygen, endobronchial valve (EBV) treatment, surgery, palliative care and clinical trials.
Learn more at Lung.org/COPD.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
American Lung Association • 55 W. Wacker Drive, Suite 1150 • Chicago, IL 60601
1331 Pennsylvania Ave. NW, Ste. 1425 North • Washington, D.C. 20004
1-800-LUNGUSA (1-800-586-4872) Lung.org
CONTACT: Jill Dale | American Lung Association
P: 312-940-7001 M:720-438-8289 E: [email protected]
SOURCE American Lung Association
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.